These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2021550)

  • 1. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
    Kuusela P; Haglund C; Roberts PJ
    Br J Cancer; 1991 Apr; 63(4):636-40. PubMed ID: 2021550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour marker CA 125 in patients with digestive tract malignancies.
    Haglund C; Kuusela P; Roberts P; Jalanko H
    Scand J Clin Lab Invest; 1991 May; 51(3):265-270. PubMed ID: 1715601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
    Haglund C; Lundin J; Kuusela P; Roberts PJ
    Br J Cancer; 1994 Sep; 70(3):487-92. PubMed ID: 8080735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
    Sakamoto K; Haga Y; Yoshimura R; Egami H; Yokoyama Y; Akagi M
    Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour markers CA 19-9 and CA 50 in digestive tract malignancies.
    Haglund C; Roberts PJ; Jalanko H; Kuusela P
    Scand J Gastroenterol; 1992; 27(3):169-74. PubMed ID: 1502477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.
    Jalanko H; Kuusela P; Roberts P; Sipponen P; Haglund CA; Mäkelä O
    J Clin Pathol; 1984 Feb; 37(2):218-22. PubMed ID: 6198342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum levels of CEA and CA 242 in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Kuusela P; Järvinen H; Roberts PJ
    Br J Cancer; 1995 Apr; 71(4):868-72. PubMed ID: 7710956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Br J Cancer; 1992 May; 65(5):731-4. PubMed ID: 1316775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y; Kawakami H; Watanabe H; Satomura Y; Ohta H; Okai T; Makino H; Toya D; Sawabu N
    Oncology; 1991; 48(4):321-6. PubMed ID: 1891175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Haglund C
    Anticancer Res; 2002; 22(4):2311-6. PubMed ID: 12174919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Br J Cancer; 1993 Apr; 67(4):852-5. PubMed ID: 8471445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer.
    Kornek G; Depisch D; Temsch EM; Scheithauer W
    J Cancer Res Clin Oncol; 1991; 117(5):493-6. PubMed ID: 1890143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
    Haglund C
    Br J Cancer; 1986 Dec; 54(6):897-901. PubMed ID: 3467786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
    Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
    Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour markers in pancreatic cancer.
    Haglund C; Roberts PJ; Kuusela P; Jalanko H
    Scand J Gastroenterol Suppl; 1986; 126():75-8. PubMed ID: 3470921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer].
    Anzai K; Kurihara M; Izumi T
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1437-47. PubMed ID: 2212836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen.
    Carpelan-Holmström MA; Haglund CH; Roberts PJ
    Dis Colon Rectum; 1996 Jul; 39(7):799-805. PubMed ID: 8674374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.